Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-11-5
pubmed:abstractText
Previously, we found that nitric oxide (NO) inhibits cutaneous vasoconstrictor responsiveness evoked by whole body cooling, as well as an orthostatic stress in the heat-stressed human (Shibasaki M, Durand S, Davis SL, Cui J, Low DA, Keller DM, Crandall CG. J Physiol 585: 627-634, 2007). However, it remains unknown whether this response occurs via NO acting through presynaptic or postsynaptic mechanisms. The aim of this study was to test the hypothesis that NO is capable of impairing cutaneous vasoconstriction via postsynaptic mechanisms. Skin blood flow was monitored over two forearm sites where intradermal microdialysis membranes were previously placed. Skin blood flow was elevated four- to fivefold through perfusion of the NO donor sodium nitroprusside at one site and through perfusion of adenosine (primarily non-NO mechanisms) at a second site. Once a plateau in vasodilation was evident, increasing concentrations of norepinephrine (1 x 10(-8) to 1 x 10(-2) M) were administrated through both microdialysis probes, while the aforementioned vasodilator agents continued to be perfused. Cutaneous vascular conductance was calculated by dividing skin blood flow by mean arterial blood pressure. The administration of norepinephrine decreased cutaneous vascular conductance at both sites. However, the dose of norepinephrine at the onset of vasoconstriction (-5.9 +/- 1.3 vs. -7.2 +/- 0.7 log M norepinephrine, P = 0.021) and the concentration of norepinephrine resulting in 50% of the maximal vasoconstrictor response (-4.9 +/- 1.2 vs. -6.1 +/- 0.2 log M norepinephrine dose; P = 0.012) occurred at significantly higher norepinephrine concentrations for the sodium nitroprusside site relative to the adenosine site, respectively. These results suggested that NO is capable of attenuating cutaneous vasoconstrictor responsiveness to norepinephrine via postsynaptic mechanisms.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-10194201, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-10658012, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-10770200, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-11208594, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-11294774, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-11568143, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-11927694, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-12076969, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-12132645, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-12372846, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-12391110, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-12670736, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-12949223, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-14684362, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-15271659, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-15539401, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-16614358, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-16614368, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-16793901, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-17272405, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-17468334, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-17947310, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-2157467, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-2335034, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-326990, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-3536836, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-4826928, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-5360442, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-7554193, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-7955145, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-8941544, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-9039113, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-9336400, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-9729553, http://linkedlifedata.com/resource/pubmed/commentcorrection/18801956-9729554
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
8750-7587
pubmed:author
pubmed:issnType
Print
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1504-8
pubmed:dateRevised
2010-9-21
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Nitric oxide inhibits cutaneous vasoconstriction to exogenous norepinephrine.
pubmed:affiliation
Department of Environmental Health, Nara Women's University, Dallas, TX, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural